Detalles de la búsqueda
1.
Automated radiochemical synthesis of pharmaceutical grade [18 F]FLT using 3-N-Boc-5'-O-dimethoxytrityl-3'-O-nosyl-thymidine precursor and its Sep-Pak® purification employing selective elution from reversed phase.
J Labelled Comp Radiopharm
; 65(8): 206-222, 2022 06 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-35466460
2.
Evaluation of Different Methods for the Detection of Anti- Thyroglobulin Autoantibody: Prevalence of Anti-Thyroglobulin Autoantibody and Anti-Microsomal Autoantibody in Thyroid Cancer Patients.
Indian J Clin Biochem
; 37(4): 473-479, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-36262779
3.
Comparison of Serum Thyroglobulin Levels in Differentiated Thyroid Cancer Patients Using In-House Developed Radioimmunoassay and Immunoradiometric Procedures.
Indian J Clin Biochem
; 34(4): 465-471, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31686734
4.
Juglone-ascorbic acid synergy inhibits metastasis and induces apoptotic cell death in poorly differentiated thyroid carcinoma by perturbing SOD and catalase activities.
J Biochem Mol Toxicol
; 32(9): e22176, 2018 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-29992683
5.
Preparation and comparative evaluation of 99m Tc-HYNIC-cNGR and 99m Tc-HYNIC-PEG2 -cNGR as tumor-targeting molecular imaging probes.
J Labelled Comp Radiopharm
; 61(2): 68-76, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29139598
6.
177 Lu-DOTMP induces G2/M cell cycle arrest and apoptosis in MG63 cell line.
J Labelled Comp Radiopharm
; 61(11): 837-846, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29923620
7.
Radiosynthesis and evaluation of a 99mTc-folic acid radiotracer prepared using [99mTcN(PNP)]2+ metal fragment.
Bioorg Med Chem Lett
; 27(5): 1329-1332, 2017 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28174106
8.
Preparation of clinical-scale 177 Lu-Rituximab: Optimization of protocols for conjugation, radiolabeling, and freeze-dried kit formulation.
J Labelled Comp Radiopharm
; 60(5): 234-241, 2017 05 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-28181275
9.
Modulation of in vivo distribution through chelator: Synthesis and evaluation of a 2-nitroimidazole-dipicolylamine-(99m)Tc(CO)3 complex for detecting tumor hypoxia.
Bioorg Med Chem Lett
; 26(1): 46-50, 2016 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26615889
10.
Availability of both [177Lu]Lu-DOTA-TATE and [90Y]Y-DOTATATE as PRRT agents for neuroendocrine tumors: can we evolve a rational sequential duo-PRRT protocol for large volume resistant tumors?
Eur J Nucl Med Mol Imaging
; 47(4): 756-758, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31628515
11.
Towards personalizing treatment strategies in mCRPC: can dual-tracer PET-CT provide insights into tumor biology, guide the optimal treatment sequence, and individualize decision-making (between chemotherapy, second-generation anti-androgens and PSMA-directed radioligand therapy) early in the disease course?
Eur J Nucl Med Mol Imaging
; 47(8): 1793-1797, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31776630
12.
Clinical Internal Dosimetry and Biodistribution of 177 Lu-DOTA-Trastuzumab in HER2-Positive Metastatic and Locally Advanced Breast Carcinoma.
Clin Nucl Med
; 49(4): e149-e155, 2024 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38350067
13.
Intricacies in the Preparation of Patient Doses of [177Lu]Lu-Rituximab and [177Lu]Lu-Trastuzumab Using Low Specific Activity [177Lu]LuCl3: Methodological Aspects.
Mol Imaging Biol
; 26(1): 61-80, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37673943
14.
Preparation and evaluation of a 99mTcN-PNP complex of sanazole analogue for detecting tumor hypoxia.
Bioorg Med Chem Lett
; 23(5): 1394-7, 2013 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-23375795
15.
A novel concept of radiosynthesis of a (99m)Tc-labeled dimeric RGD peptide as a potential radiotracer for tumor imaging.
Bioorg Med Chem Lett
; 23(6): 1808-12, 2013 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-23414841
16.
Envisaging an alpha therapy programme in the atomic energy establishments: the priorities and the nuances.
Eur J Nucl Med Mol Imaging
; 44(7): 1244-1246, 2017 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-28364163
17.
Lutetium-177 therapeutic radiopharmaceuticals: linking chemistry, radiochemistry, and practical applications.
Chem Rev
; 115(8): 2934-74, 2015 Apr 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-25865818
18.
Estimation of Absorbed Doses of Indigenously Produced "Direct-route" Lutetium-177-[177Lu]Lu-DOTA-TATE PRRT in Normal Organs and Tumor Lesions in Patients of Metastatic Neuroendocrine Tumors: Comparison with No-Carrier-Added [177Lu]Lu-DOTA-TATE and the Trend with Multiple Cycles.
Cancer Biother Radiopharm
; 37(3): 214-225, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-34910891
19.
Clinical Dose Preparation of [177Lu]Lu-DOTA-Pertuzumab Using Medium Specific Activity [177Lu]LuCl3 for Radioimmunotherapy of Breast and Epithelial Ovarian Cancers, with HER2 Receptor Overexpression.
Cancer Biother Radiopharm
; 37(5): 384-402, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35575711
20.
Initial clinical evaluation of indigenous 90Y-DOTATATE in sequential duo-PRRT approach (177Lu-DOTATATE and 90Y-DOTATATE) in neuroendocrine tumors with large bulky disease: Observation on tolerability, 90Y-DOTATATE post- PRRT imaging characteristics (bremsstrahlung and PETCT) and early adverse effects.
World J Nucl Med
; 20(1): 73-81, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33850492